ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,331 | -9.2% | 335,359 | -1.2% | 0.00% | – |
| Q2 2023 | $546,503 | -42.1% | 339,443 | +4.3% | 0.00% | – |
| Q1 2023 | $944,159 | -9.9% | 325,572 | +1.9% | 0.00% | – |
| Q4 2022 | $1,047,980 | -56.8% | 319,506 | -50.2% | 0.00% | -100.0% |
| Q3 2022 | $2,427,000 | +5.7% | 642,158 | +117.8% | 0.00% | 0.0% |
| Q2 2022 | $2,297,000 | -21.6% | 294,897 | -6.5% | 0.00% | 0.0% |
| Q1 2022 | $2,929,000 | -39.9% | 315,267 | +1.9% | 0.00% | 0.0% |
| Q4 2021 | $4,875,000 | -10.1% | 309,307 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $5,424,000 | +25.9% | 303,031 | +9.4% | 0.00% | 0.0% |
| Q2 2021 | $4,307,000 | +1.3% | 277,046 | -6.4% | 0.00% | 0.0% |
| Q1 2021 | $4,251,000 | -29.1% | 296,088 | -3.1% | 0.00% | 0.0% |
| Q4 2020 | $5,998,000 | +67.7% | 305,613 | +10.8% | 0.00% | 0.0% |
| Q3 2020 | $3,576,000 | -0.4% | 275,918 | +12.0% | 0.00% | 0.0% |
| Q2 2020 | $3,589,000 | +93.7% | 246,330 | +13.2% | 0.00% | 0.0% |
| Q1 2020 | $1,853,000 | -46.9% | 217,692 | +2.8% | 0.00% | 0.0% |
| Q4 2019 | $3,488,000 | +12.2% | 211,796 | -3.8% | 0.00% | 0.0% |
| Q3 2019 | $3,110,000 | -20.1% | 220,203 | +13.8% | 0.00% | 0.0% |
| Q2 2019 | $3,891,000 | -47.0% | 193,454 | +4.8% | 0.00% | -50.0% |
| Q1 2019 | $7,335,000 | +13.7% | 184,513 | -0.6% | 0.00% | 0.0% |
| Q4 2018 | $6,450,000 | -13.1% | 185,680 | +3.4% | 0.00% | 0.0% |
| Q3 2018 | $7,422,000 | +13.1% | 179,505 | +0.5% | 0.00% | 0.0% |
| Q2 2018 | $6,565,000 | -2.2% | 178,642 | +3.8% | 0.00% | 0.0% |
| Q1 2018 | $6,715,000 | +187.1% | 172,183 | +33.2% | 0.00% | +100.0% |
| Q4 2017 | $2,339,000 | +14.2% | 129,237 | +4.4% | 0.00% | 0.0% |
| Q3 2017 | $2,049,000 | +16.4% | 123,822 | -1.5% | 0.00% | – |
| Q2 2017 | $1,760,000 | -28.7% | 125,713 | +4.7% | 0.00% | -100.0% |
| Q1 2017 | $2,468,000 | +52.3% | 120,097 | +5.3% | 0.00% | – |
| Q4 2016 | $1,620,000 | -20.0% | 114,028 | +20.5% | 0.00% | -100.0% |
| Q3 2016 | $2,024,000 | -9.8% | 94,653 | -5.0% | 0.00% | 0.0% |
| Q2 2016 | $2,243,000 | +43.0% | 99,629 | +20.9% | 0.00% | – |
| Q1 2016 | $1,568,000 | -32.1% | 82,434 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $2,308,000 | -16.7% | 87,414 | -0.8% | 0.00% | 0.0% |
| Q3 2015 | $2,772,000 | -30.9% | 88,160 | +15.9% | 0.00% | 0.0% |
| Q2 2015 | $4,012,000 | +222.0% | 76,044 | +153.7% | 0.00% | – |
| Q1 2015 | $1,246,000 | +133.3% | 29,978 | +50.3% | 0.00% | – |
| Q4 2014 | $534,000 | – | 19,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |